Symptomatic and asymptomatic carotid artery plaque.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 3243497)

Published in Expert Rev Cardiovasc Ther on October 01, 2011

Authors

Majid M Mughal1, Mohsin K Khan, J Kevin DeMarco, Arshad Majid, Fadi Shamoun, George S Abela

Author Affiliations

1: Department of Medicine, Division of Cardiology, Michigan State University, 138 Service Road, B208 Clinical Center, East Lansing, MI 48824, USA.

Associated clinical trials:

Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms (3TMR) | NCT02335567

Articles cited by this

Inflammation in atherosclerosis. Nature (2002) 28.92

Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89

Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet (2003) 17.34

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet (2004) 16.23

Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA (1995) 15.80

High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79

Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59

Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke (2010) 10.66

Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet (1998) 10.64

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature (2010) 10.60

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet (2004) 9.41

Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18

Pathology of the vulnerable plaque. J Am Coll Cardiol (2006) 7.79

Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet (2007) 7.27

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest (1994) 7.25

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J (1985) 5.83

Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol (2010) 5.79

Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med (2003) 5.43

Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial results. Stroke (2006) 4.85

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol (1995) 4.43

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation (2002) 4.43

Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol (2010) 4.01

Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med (1993) 3.93

Risk of stroke in the distribution of an asymptomatic carotid artery. The European Carotid Surgery Trialists Collaborative Group. Lancet (1995) 3.61

Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke (2003) 3.41

Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med (1984) 3.41

Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol (2004) 3.37

In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation (2005) 2.76

Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol (2000) 2.66

Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol (2005) 2.65

Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke (1999) 2.56

Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res (1992) 2.53

Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation (2000) 2.38

Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke (2009) 2.15

Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation (1997) 2.12

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke (1997) 1.86

Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol (1994) 1.84

Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol (2008) 1.77

Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J (2004) 1.68

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol (2011) 1.67

Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 1.66

Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg (1996) 1.63

Moderate carotid artery stenosis: MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology (2009) 1.59

Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA. Neurology (2004) 1.57

Association between carotid atherosclerosis plaque with high signal intensity on T1-weighted imaging and subsequent ipsilateral ischemic events. Neurosurgery (2011) 1.56

Comparison of dual-source CT angiography and MR angiography in preoperative evaluation of intra- and extracranial vessels: a pilot study. Eur Radiol (2009) 1.51

Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am J Cardiol (2009) 1.44

Transcranial Doppler sonography and magnetic resonance angiography in the assessment of collateral hemispheric flow in patients with carotid artery disease. Stroke (1995) 1.44

Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol (1996) 1.43

Clinical application of asymptomatic embolic signal detection in acute stroke: a prospective study. Stroke (1999) 1.43

Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg (2010) 1.31

Neovascularization in human atherosclerosis. Curr Mol Med (2006) 1.30

High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol (2010) 1.26

Carotid intraplaque hemorrhage imaging at 3.0-T MR imaging: comparison of the diagnostic performance of three T1-weighted sequences. Radiology (2010) 1.24

Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation (2008) 1.22

Do carotid bruits predict disease of the internal carotid arteries? Postgrad Med J (1994) 1.20

Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. Circulation (1998) 1.18

Assessment by cardiovascular magnetic resonance, electron beam computed tomography, and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata. Am J Cardiol (2006) 1.14

Carotid plaque formation and serum biomarkers. Atherosclerosis (2010) 1.11

A model for predicting occult carotid artery stenosis: screening is justified in a selected population. J Vasc Surg (2003) 1.10

Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events--a novel insight into plaque rupture by scanning electron microscopy. Scanning (2006) 1.10

Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation. J Clin Lipidol (2010) 1.07

Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke (1998) 1.07

Predictors of surface disruption with MR imaging in asymptomatic carotid artery stenosis. AJNR Am J Neuroradiol (2009) 1.02

Hemorrhage and large lipid-rich necrotic cores are independently associated with thin or ruptured fibrous caps: an in vivo 3T MRI study. Arterioscler Thromb Vasc Biol (2009) 1.01

Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood (1995) 1.00

CT angiographic analysis of carotid artery stenosis: comparison of manual assessment, semiautomatic vessel analysis, and digital subtraction angiography. AJNR Am J Neuroradiol (2007) 0.99

Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen. J Lipid Res (2003) 0.98

Plaque hemorrhage is a marker of thromboembolic activity in patients with symptomatic carotid disease. Radiology (2010) 0.96

Towards understanding acute destabilization of vulnerable atherosclerotic plaques. Cardiovasc Pathol (2003) 0.95

Histological features of symptomatic carotid plaques in relation to age and smoking: the oxford plaque study. Stroke (2010) 0.92

Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries. Invest Radiol (2000) 0.92

Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery (1997) 0.92

Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. Am J Cardiol (2011) 0.87

Ultrasound densitometric analysis of carotid plaque composition. Pathoanatomic correlation. Stroke (1996) 0.87

Physical factors that trigger cholesterol crystallization leading to plaque rupture. Atherosclerosis (2008) 0.87

Sex differences in patients with asymptomatic carotid atherosclerotic plaque: in vivo 3.0-T magnetic resonance study. Stroke (2010) 0.84

Prevalence and outcome of asymptomatic carotid stenosis: a population-based ultrasonographic study. Eur J Neurol (2002) 0.81

Carotid MRI: a tool for monitoring individual response to cardiovascular therapy? Expert Rev Cardiovasc Ther (2011) 0.80

Parallel cholesterol crystals: a sign of impending plaque rupture? J Invasive Cardiol (2010) 0.80

The impact of circulating cholesterol crystals on vasomotor function: implications for no-reflow phenomenon. JACC Cardiovasc Interv (2011) 0.77

High definition imaging of carotid arteries using a standard commercial ultrasound "B" scanner. A preliminary report. Br J Radiol (1979) 0.76

[B-scan sonography of the carotid artery. Technique, results and indications (author's transl)]. Rofo (1981) 0.76

Articles by these authors

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature (2010) 10.60

Cardiovascular manifestations in human immunodeficiency virus-infected patients. Am J Cardiol (2008) 1.77

Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke (2014) 1.77

Effect of pretreatment with statins on ischemic stroke outcomes. Stroke (2008) 1.63

Cardiac dysfunction after left permanent cerebral focal ischemia: the brain and heart connection. Stroke (2009) 1.51

Statin therapy decreases myocardial function as evaluated via strain imaging. Clin Cardiol (2009) 1.44

Quadricuspid aortic valve: a rare entity. Clin Cardiol (2005) 1.38

Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol (2008) 1.35

The potential of minocycline for neuroprotection in human neurologic disease. Clin Neuropharmacol (2004) 1.30

Magnetic resonance imaging study of the effects of age and accommodation on the human lens cross-sectional area. Invest Ophthalmol Vis Sci (2004) 1.25

Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation (2008) 1.22

Chemotherapy-related posterior reversible leukoencephalopathy syndrome. Nat Clin Pract Neurol (2009) 1.21

Carnosine is neuroprotective against permanent focal cerebral ischemia in mice. Stroke (2007) 1.18

Coronary artery fistula: a case series with review of the literature. J Cardiol (2008) 1.14

In-hospital stroke in a statewide stroke registry. Cerebrovasc Dis (2007) 1.11

An optimized 3D inversion recovery prepared fast spoiled gradient recalled sequence for carotid plaque hemorrhage imaging at 3.0 T. Magn Reson Imaging (2008) 1.07

Extent of intra-arterial calcification on head CT is predictive of the degree of intracranial atherosclerosis on digital subtraction angiography. Cerebrovasc Dis (2009) 1.06

The role of optical coherence tomography in vascular medicine. Vasc Med (2009) 1.05

Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia. J Neurosci Res (2009) 1.05

Unusual complications of coronary artery bypass graft surgery. Am J Cardiol (2006) 1.02

Peripheral neuropathy: differential diagnosis and management. Am Fam Physician (2010) 1.00

Prophylaxis to prevent infective endocarditis: to use or not to use? Clin Cardiol (2009) 0.99

Lower pretreatment cerebral blood volume affects hemorrhagic risks after intra-arterial revascularization in acute stroke. Neurosurgery (2008) 0.94

The mTOR pathway as a potential target for the development of therapies against neurological disease. Drug News Perspect (2007) 0.94

Periodic lateralized epileptiform discharges: an initial electrographic pattern in reversible posterior leukoencephalopathy syndrome. Neurol Neurochir Pol (2008) 0.93

Levetiracetam for managing neurologic and psychiatric disorders. Am J Health Syst Pharm (2009) 0.92

Medicolegal considerations with intravenous tissue plasminogen activator in stroke: a systematic review. Stroke Res Treat (2013) 0.90

Ischemia and ischemic tolerance in the brain: an overview. Neurotoxicology (2004) 0.90

Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy? Vasc Med (2007) 0.89

Differential neuroprotective effects of carnosine, anserine, and N-acetyl carnosine against permanent focal ischemia. J Neurosci Res (2008) 0.89

Predictors of occult paroxysmal atrial fibrillation in cryptogenic strokes detected by long-term noninvasive cardiac monitoring. Stroke Res Treat (2011) 0.89

Neuroprotective effect of cyanidin-3-O-glucoside anthocyanin in mice with focal cerebral ischemia. Neurosci Lett (2011) 0.89

Current concepts in triglyceride metabolism, pathophysiology, and treatment. Metabolism (2010) 0.88

Safety and efficacy evaluation of carnosine, an endogenous neuroprotective agent for ischemic stroke. Stroke (2012) 0.88

Asiatic acid attenuates infarct volume, mitochondrial dysfunction, and matrix metalloproteinase-9 induction after focal cerebral ischemia. Stroke (2012) 0.88

Atheromatous plaque cap thickness can be determined by quantitative color analysis during angioscopy: implications for identifying the vulnerable plaque. Clin Cardiol (2004) 0.88

Update on coronary angioscopy: review of a 20-year experience and potential application for detection of vulnerable plaque. J Interv Cardiol (2006) 0.87

Inhibition of brain GTP cyclohydrolase I and tetrahydrobiopterin attenuates cerebral infarction via reducing inducible NO synthase and peroxynitrite in ischemic stroke. Stroke (2005) 0.87

The influence of bolus to infusion delays on plasma Tissue Plasminogen Activator levels. Int J Stroke (2012) 0.87

Physical factors that trigger cholesterol crystallization leading to plaque rupture. Atherosclerosis (2008) 0.87

Distinguishing characteristics of erythrocyte-rich and platelet-rich thrombus by intravascular ultrasound catheter system. J Thromb Thrombolysis (2007) 0.86

Amiodarone - a 'broad spectrum' antiarrhythmic drug. Cardiovasc Hematol Disord Drug Targets (2010) 0.86

A quantitative measure of myelination development in infants, using MR images. Neuroradiology (2004) 0.86

Role of sildenafil in neurological disorders. Clin Neuropharmacol (2008) 0.86

An optimized 3D spoiled gradient recalled echo pulse sequence for hemorrhage assessment using inversion recovery and multiple echoes (3D SHINE) for carotid plaque imaging. Magn Reson Med (2010) 0.86

A potential biomarker in sports-related concussion: brain functional connectivity alteration of the default-mode network measured with longitudinal resting-state fMRI over thirty days. J Neurotrauma (2014) 0.85

Early risk, attention, and brain activation in adolescents born preterm. Child Dev (2006) 0.85

Blood pressure changes after intravenous fosphenytoin and levetiracetam in patients with acute cerebral symptoms. Epilepsy Res (2009) 0.85

Transcranial Doppler: an introduction for primary care physicians. J Am Board Fam Med (2007) 0.85

Implementation of an emergency department based transient ischemic attack clinical pathway: a pilot study in knowledge translation. Acad Emerg Med (2007) 0.85

Primary cardiac pleomorphic sarcoma presenting as back pain in an 18-year-old man. Tex Heart Inst J (2013) 0.85

Hypercholesterolemia and myocardial function evaluated via tissue doppler imaging. Cardiovasc Ultrasound (2009) 0.85

Sex differences in patients with asymptomatic carotid atherosclerotic plaque: in vivo 3.0-T magnetic resonance study. Stroke (2010) 0.84

Amplification of atherosclerotic calcification and Mönckeberg's sclerosis: a spectrum of the same disease process. Adv Chronic Kidney Dis (2008) 0.84

Cor triatriatum sinister with bicuspid aortic valve: a rare association. Clin Cardiol (2009) 0.84

Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography. Arterioscler Thromb Vasc Biol (2011) 0.83

IV levetiracetam in the management of non-convulsive status epilepticus. Neurocrit Care (2007) 0.83

Neuroprotective effect of asiatic acid in rat model of focal embolic stroke. Biol Pharm Bull (2014) 0.82

Role of histidine/histamine in carnosine-induced neuroprotection during ischemic brain damage. Brain Res (2013) 0.82

Deletion of the mouse alpha-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2008) 0.81

Elevated levels of pre-procedural high-sensitivity C-reactive protein is associated with midterm restenosis after extra- and intracranial stenting. J Neuroimaging (2008) 0.81

Cardiovascular complications of the Guillain-Barré syndrome. Am J Cardiol (2009) 0.81

Overtures to takotsubo's cardiomyopathy. Clin Cardiol (2011) 0.81

Plaque disruption and thrombus in Ambrose's angiographic coronary lesion types. Am J Cardiol (2003) 0.81

Hemodynamic collapse during left ventricular lead implantation. Pacing Clin Electrophysiol (2007) 0.80

Coagulopathy and Extremely Elevated PT/INR after Dabigatran Etexilate Use in a Patient with End-Stage Renal Disease. Case Rep Med (2013) 0.80

Stroke symptoms and risk factor awareness in high school children in Pakistan. Int J Stroke (2012) 0.80

CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging. Pharm Res (2013) 0.80

Arterial wall cholesterol content is a predictor of development and severity of arterial thrombosis. J Thromb Thrombolysis (2006) 0.80

Anesthesia for endovascular treatment of acute ischemic stroke. Neurology (2012) 0.80

Cocaine and alcohol: a potential lethal duo. Am J Med (2009) 0.79

Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery. Clin Cardiol (2013) 0.79

Cardiac tissue Doppler and tissue velocity imaging in anesthetized New Zealand white rabbits. J Am Assoc Lab Anim Sci (2011) 0.78

Synthesis of β-cyclodextrin conjugated superparamagnetic iron oxide nanoparticles for selective binding and detection of cholesterol crystals. Chem Commun (Camb) (2012) 0.78

Transcranial Doppler measurements in migraine and nitroglycerin headache. J Headache Pain (2007) 0.78

Clinical significance of serum zinc levels in cerebral ischemia. Stroke Res Treat (2011) 0.77

The impact of stent strut porosity on reducing flow in cerebral aneurysms. J Neuroimaging (2013) 0.77

Myocardial ischemia/reperfusion injury: potential of TRPV1 agonists as cardioprotective agents. Cardiovasc Hematol Disord Drug Targets (2014) 0.77

The impact of circulating cholesterol crystals on vasomotor function: implications for no-reflow phenomenon. JACC Cardiovasc Interv (2011) 0.77

Lymphocyte cell kinase activation mediates neuroprotection during ischemic preconditioning. J Neurosci (2012) 0.77

Chronic total symptomatic carotid artery occlusion treated successfully with stenting and angioplasty. J Neuroimaging (2008) 0.77

Endovascular treatment of symptomatic intracranial atherosclerotic disease. Front Neurol (2011) 0.76

The WHO STEPwise Approach to Stroke Surveillance. J Coll Physicians Surg Pak (2008) 0.76

Ultrasound Characteristics of Symptomatic Carotid Plaques: A Systematic Review and Meta-Analysis. Cerebrovasc Dis (2015) 0.76

Treatment of a basilar artery occlusion with intra-arterial thrombolysis in a 3-year-old girl. Neurocrit Care (2008) 0.76

3.0 T versus 1.5 T MR angiography of the head and neck. Neuroimaging Clin N Am (2006) 0.76

Initial experience with balanced turbo field echo in depicting carotid artery stenosis: comparison with multiple overlapping thin slab acquisition and 3D contrast-enhanced magnetic resonance angiography. J Magn Reson Imaging (2005) 0.75

Evolution of curative therapies for atrial fibrillation review. Indian Pacing Electrophysiol J (2004) 0.75

Likelihood of ventricular arrhythmias due to myocardial fibrosis in hypertrophic cardiomyopathy as detected by cardiac magnetic resonance imaging. J Am Coll Cardiol (2008) 0.75

US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke (2007) 0.75

Peaked T--waves and sinus arrhythmia before prolonged sinus pauses and atrioventricular block in guillain-barre syndrome. Indian Pacing Electrophysiol J (2007) 0.75

The effect of ethanol on cholesterol crystals during tissue preparation for scanning electron microscopy. J Am Coll Cardiol (2012) 0.75

Distribution of carnosine-like peptides in the nervous system of developing and adult zebrafish (Danio rerio) and embryonic effects of chronic carnosine exposure. Cell Tissue Res (2009) 0.75

ABCD2 Score and Large-Artery Atherosclerosis. Neurohospitalist (2012) 0.75

Assessment of Patient Adherence to Direct Oral Anticoagulant vs Warfarin Therapy. J Am Osteopath Assoc (2017) 0.75

Shaft aneurysm of femoropopliteal expanded polytetrafluoroethylene graft treated with a covered stent. Vasc Endovascular Surg (2008) 0.75

Rapidly progressive infective endocarditis without features of systemic inflammation resulting in perforation of the native aortic valve. J Heart Valve Dis (2011) 0.75

Relation of porphyria to atrial fibrillation. Am J Cardiol (2009) 0.75